Polpharma is a Poland-based CDMO and API producer. With over 70 years of experience, it is Poland's biggest API manufacturer. It provides its customers with materials ranging from clinical quantities up to market supply. Polpharma has fully integrated all of its operations, from R&D to manufacturing, leveraging all its key competencies to deliver cost-effective and on-time solutions to its customers. It manufactures APIs at a cGMP-compliant and FDA-approved multipurpose plant. It has invested US$ 45 million to expand its API plant in Starogard Gdanski to include HPAPI and cryogenic technologies, as well as a pilot plant and R&D capabilities.